Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Telecanthus-hypertelorism-strabismus-pes cavus syndrome is characterized by telecanthus, hypertelorism, strabismus, pes cavus and other variable anomalies. It has been described in a father and his son. The son also had hypospadias, bilateral inguinal hernia, clinodactyly and camptodactyly of the fingers, and radiographic findings including flared metaphyses of the long bones and osteopenia.
Biomarker and diagnostic research for telecanthus-hypertelorism-strabismus-pes cavus syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for telecanthus-hypertelorism-strabismus-pes cavus syndrome.
26 publications have been identified in PubMed for telecanthus-hypertelorism-strabismus-pes cavus syndrome. Kisho has analyzed 17 by research type. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (29%), and Diagnostic / Biomarker (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 47% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:34 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
5 |
29% |
Testing and diagnosis research | 2 | 12% |
Disease patterns and progression | 2 | 12% |
Baris S (2026). [PMID: 41683799](https://pubmed.ncbi.nlm.nih.gov/41683799/). *Int J Mol Sci*. [Case Report / Case Series]
Mutlu U (2026). [PMID: 41507929](https://pubmed.ncbi.nlm.nih.gov/41507929/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Agrawal PK (2025). [PMID: 41089971](https://pubmed.ncbi.nlm.nih.gov/41089971/). *J Family Med Prim Care*. [Case Report / Case Series]
Al Ojaimi M (2025). [PMID: 40301961](https://pubmed.ncbi.nlm.nih.gov/40301961/). *Hum Genomics*. [Review / Meta-Analysis]
Padgett AM (2025). [PMID: 40382509](https://pubmed.ncbi.nlm.nih.gov/40382509/). *Childs Nerv Syst*. [Epidemiology / Natural History]
Aslanger EK (2025). [PMID: 41128712](https://pubmed.ncbi.nlm.nih.gov/41128712/). *JACC Adv*. [Diagnostic / Biomarker]
Alqahtani AM (2025). [PMID: 41089586](https://pubmed.ncbi.nlm.nih.gov/41089586/). *Cureus*. [Case Report / Case Series]
Ren L (2025). [PMID: 40922349](https://pubmed.ncbi.nlm.nih.gov/40922349/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Mutlu U (2025). [PMID: 39840823](https://pubmed.ncbi.nlm.nih.gov/39840823/). *Turk J Gastroenterol*. [Diagnostic / Biomarker]
Yanartaş MS (2025). [PMID: 41480049](https://pubmed.ncbi.nlm.nih.gov/41480049/). *Mol Syndromol*. [Case Report / Case Series]